Tag: pharma
20 Jul, 2021
Three key benefits of decentralised clinical trials
An estimated 80% of non-COVID-19 trials were paused or cancelled as a result of the pandemic. That means that 1000s of trials and drug developments have been…
02 Jul, 2021
COVID: The catalyst of decentralised clinical trials?
The clinical research industry is one of many rules, regulations, processes, systems, privacy requirements and much, much more – for good reason. The safety of the patient,…
28 Jun, 2021
Arkivum report: TMF Futures 2021, Good data in the age of digital transformation
TMF Futures 2021: Good data in the age of digital transformation This 2021 report is drawn from our second annual TMF Futures survey. Polling the views of…
19 May, 2021
Reviewing quality and completeness for Study Lock and Archival
The European Medicines Agency (EMA) Guidelines on the content, management, and archiving of the clinical Trial Master File (paper and/or electronic), were finalised at the end of…
29 Mar, 2021
Should you build or buy your eTMF archival solution?
The build vs buy conundrum for businesses is not new when it comes to decisions around implementing new software. For drug sponsors, regulatory requirements to manage the…
05 Mar, 2021
New survey on digital strategies for clinical trial data
Arkivum and the future of data in the life sciences industry Deepening our understanding of the life sciences industry, particularly around the management of clinical trial data,…
